HLA-A*02:01-positive tumor cell lines with varying levels of PRAME mRNA and derived from different indications were used as target cells to analyze the effector functions of the two TCR-T populations in vitro (Figure 2C). The gene discussed is PRAME; the disease is neoplasm.